drugset / Trial / NCT01832935

Cost Effectiveness of Glargine Insulin Versus NPH Insulin

NCT01832935

Phase 4 Completed 200 enrolled Tehran University of Medical Sciences
RandomizedParallel-groupDouble-blindBasic science

Summary

Glycemic control is fundamental in the management of diabetes mellitus .If lifestyle intervention and full tolerated doses of one or two oral glucose lowering drugs (OGLDs) fail to achieve or sustain glycemic goals, insulin should be initiated. New insulin analogs are generated to improve glycemic control .New insulin analogs are generated to improve glycemic control,However, the cost of these analogs is a major problem .The aim of this piggy back evaluation was to assess the effect of Glargine insuline versus NPH plus regular human insulin on metabolic control as well as its cost-effectiveness in people with type 2 diabetes in the Iranian setting.

Timeline

Start
2011-07
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator insulin NPH Protein / enzyme biologic 24 iu
Comparator insulin glargine Protein / enzyme biologic 24 iu